EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism

Mario Mastrangelo iD, Manuela Tolve, Cristiana Artiola, Rossella Bove, Claudia Carducci iD, Carla Carducci iD, Antonio Angeloni, Francesco Pisani, Vincenzo Leuzzi iD

Genes · 2023

DOI: 10.3390/genes14020263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Mario Mastrangelo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Child Neurology and Psychiatry Unit, Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Movement Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited disorders of biogenic amine metabolism are genetically determined conditions resulting in dysfunctions or lack of enzymes involved in the synthesis, degradation, or transport of dopamine, serotonin, adrenaline/noradrenaline, and their metabolites or defects of their cofactor or chaperone biosynthesis. They represent a group of treatable diseases presenting with complex patterns of movement disorders (dystonia, oculogyric crises, severe/hypokinetic syndrome, myoclonic jerks, and tremors) associated with a delay in the emergence of postural reactions, global development delay, and autonomic dysregulation. The earlier the disease manifests, the more severe and widespread the impaired motor functions. Diagnosis mainly depends on measuring neurotransmitter metabolites in cerebrospinal fluid that may address the genetic confirmation. Correlations between the severity of phenotypes and genotypes may vary remarkably among the different diseases. Traditional pharmacological strategies are not disease-modifying in most cases. Gene therapy has provided promising results in patients with DYT-DDC and in vitro models of DYT/PARK-SLC6A3. The rarity of these diseases, combined with limited knowledge of their clinical, biochemical, and molecular genetic features, frequently leads to misdiagnosis or significant diagnostic delays. This review provides updates on these aspects with a final outlook on future perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Movement DisordersHumansDopamineNeurotransmitter AgentsGenotypePhenotype

Stichwörter der Autor:innen

dystoniaencephalopathymovement disordersneurotransmitter disordersparkinsonism

Substanzen

DopamineNeurotransmitter Agents

Autor:innen und Institutionen

  • Child Neurology and Psychiatry Unit, Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy.
  • Azienda Ospedaliero Universitaria Policlinico Umberto I, 00161 Rome, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

ORCID-Profile: Mario Mastrangelo, Claudia Carducci, Carla Carducci, Vincenzo Leuzzi

Zitieren

APA

Mastrangelo, M., Tolve, M., Artiola, C., Bove, R., Carducci, C., Carducci, C., Angeloni, A., Pisani, F., & Leuzzi, V. (2023). Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism. Genes. https://doi.org/10.3390/genes14020263

Vancouver

Mastrangelo M, Tolve M, Artiola C, Bove R, Carducci C, Carducci C, et al. Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism. Genes. 2023. doi:10.3390/genes14020263

BibTeX
@article{Mastrangelo2023,
  author = {Mastrangelo, Mario and Tolve, Manuela and Artiola, Cristiana and Bove, Rossella and Carducci, Claudia and Carducci, Carla and Angeloni, Antonio and Pisani, Francesco and Leuzzi, Vincenzo},
  title = {Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14020263}
}
Kostenlos starten →